Role and uptake of human papillomavirus vaccine in adolescent health in the United States

References

• BoschFXManosMMMunozNPrevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study GroupJ Natl Cancer Inst199587117968027791229
   PubMed Web of Science ®Google Scholar
• MarcellAAdolescenceKliegmanRMBehrmanREJensonHBStantonBFNelson Textbook of Pediatrics18th edPhiladelphia, PASaunders Elsevier2007
   Google Scholar
• WinerRLLeeSKHughesJPGenital human papillomavirus infection: incidence and risk factors in a cohort of female university studentsAm J Epidemiol2003157321822612543621
   PubMed Web of Science ®Google Scholar
• AbmaJCMartinezGMMosherWDDawsonBSTeenagers in the United States: sexual activity, contraceptive use, and childbearing, 2002. National Center for Health StatisticsVital Health Stat20042324148
   Google Scholar
• EatonDKKannLKinchenSYouth risk behavior surveillance – United States, 2005Morb Mortal Wkly Rep Surveill Summ20065551108
   PubMedGoogle Scholar
• WeinstockHBermanSCatesWJrSexually transmitted diseases among American youth: incidence and prevalence estimates, 2000Perspect Sex Reprod Health200436161014982671
   PubMed Web of Science ®Google Scholar
• BartholomewDAHuman papillomavirus infection in adolescents: a rational approachAdolesc Med Clin200415356959515625994
   PubMedGoogle Scholar
• FisherMRosenfeldWDBurkRDCervicovaginal human papillomavirus infection in suburban adolescents and young adultsJ Pediatr199111958218251658285
   PubMed Web of Science ®Google Scholar
• MoscickiABPalefskyJGonzalesJSchoolnikGKHuman papillomavirus infection in sexually active adolescent females: prevalence and risk factorsPediatr Res19902855075132175024
   PubMed Web of Science ®Google Scholar
• FerreccioCPradoRBLuzoroAVPopulation-based prevalence and age distribution of human papillomavirus among women in Santiago, ChileCancer Epidemiol Biomarkers Prev200413122271227615598792
   PubMed Web of Science ®Google Scholar
• ShermanMESchiffmanMCoxJTEffects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)J Natl Cancer Inst200294210210711792748
   PubMedGoogle Scholar
• BrownDRShewMLQadadriBA longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent womenJ Infect Dis2005191218219215609227
   PubMed Web of Science ®Google Scholar
• MoscickiABGenital HPV infections in children and adolescentsObstet Gynecol Clin North Am19962336756978869952
   PubMed Web of Science ®Google Scholar
• StanleyMHPV – immune response to infection and vaccinationInfect Agent Cancer201051920961432
   PubMedGoogle Scholar
• WalboomersJMJacobsMVManosMMHuman papillomavirus is a necessary cause of invasive cervical cancer worldwideJ Pathol19991891121910451482
   PubMed Web of Science ®Google Scholar
• SchiffmanMHCastlePEpidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasiaJ Natl Cancer Inst2003956E212644550
   PubMedGoogle Scholar
• BoschFXLorinczAMunozNMeijerCJShahKVThe causal relation between human papillomavirus and cervical cancerJ Clin Pathol200255424426511919208
   PubMed Web of Science ®Google Scholar
• BoschFXEpidemiology of human papillomavirus infections: new options for cervical cancer preventionSalud Publica Mex200345SupplS326S339 Spanish14746025
   PubMed Web of Science ®Google Scholar
• BoschFXde SanjoseSHuman papillomavirus in cervical cancerCurr Oncol Rep20024217518311822990
   PubMedGoogle Scholar
• LiddonNHoodJWynnBAMarkowitzLEAcceptability of human papillomavirus vaccine for males: a review of the literatureJ Adolesc Health201046211312320113917
   PubMed Web of Science ®Google Scholar
• KjaerSKTranTNSparenPThe burden of genital warts: A study of nearly 70,000 women from the general female population in the 4 Nordic countriesJ Infect Dis2007196101447145418008222
   PubMed Web of Science ®Google Scholar
• PallecarosAVonauBHuman papilloma virus vaccine – more than a vaccineCurr Opin Obstet Gynecol200719654154618007131
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationApproval letter: human papillomavirus quadrivalent (types 6, 11, 16, 18) vaccine, recombinant682006 Available from: http://www.fda.gov/BiologicsBlood-Vaccines/Vaccines/ApprovedProducts/ucm111283.htmAccessed May 28, 2011
   Google Scholar
• US Food and Drug AdministrationFDA approves new vaccine for prevention of cervical cancer10162009 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187048.htmAccessed February 16, 2011
   Google Scholar
• US Prescribing Information for GARDASIL® updated; Indication not granted for use in adult women462011 Available from: http://www.merck.com/newsroom/news-release-archive/vaccine-news/2011_0406.htmlAccessed May 28, 2011
   Google Scholar
• GarlandSMHernandez-AvilaMWheelerCMQuadrivalent vaccine against human papillomavirus to prevent anogenital diseasesN Engl J Med2007356191928194317494926
   PubMed Web of Science ®Google Scholar
• PaavonenJNaudPSalmeronJEfficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenLancet2009374968630131419586656
   PubMed Web of Science ®Google Scholar
• RomanowskiBde BorbaPCNaudPSSustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 yearsLancet200937497061975198519962185
   PubMed Web of Science ®Google Scholar
• GiulianoARPalefskyJMGoldstoneSEfficacy of quadrivalent HPV vaccine against HPV infection and disease in malesN Engl J Med2011364540141121288094
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA approves new indication for gardasil to prevent genital warts in men and boys10162009 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187003.htmAccessed May 28, 2011
   Google Scholar
• VillaLLAultKAGiulianoARImmunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18Vaccine20062427–285571558316753240
   PubMed Web of Science ®Google Scholar
• BlockSLNolanTSattlerCComparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult womenPediatrics200611852135214517079588
   PubMed Web of Science ®Google Scholar
• KoutskyLEpidemiology of genital human papillomavirus infectionAm J Med19971025A389217656
   PubMedGoogle Scholar
• Clinicaltrials.govUS NLoM. Identifier NCT01077856, Vaccine Impact in Population Study (VIP)2006 Available from: http://clinicaltrials.gov/ct2/show/NCT01077856Accessed May 30, 2011
   Google Scholar
• LeeYCNewportMJGoetghebuerTInfluence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twinsVaccine200624255335534016701924
   PubMed Web of Science ®Google Scholar
• NewportMJGoetghebuerTWeissHAGenetic regulation of immune responses to vaccines in early lifeGenes Immun20045212212914737096
   PubMed Web of Science ®Google Scholar
• NewportMJGoetghebuerTMarchantAHunting for immune response regulatory genes: vaccination studies in infant twinsExpert Rev Vaccines20054573974616221074
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)MMWR Morb Mortal Wkly Rep2010592063063220508594
   PubMedGoogle Scholar
• Barnholtz-SloanJPatelNRollisonDIncidence trends of invasive cervical cancer in the United States by combined race and ethnicityCancer Causes Control20092071129113819253025
   PubMed Web of Science ®Google Scholar
• Committee on Adolescent Health CareACOG Committee Opinion No. 436: evaluation and management of abnormal cervical cytology and histology in adolescentsObstet Gynecol200911361422142519461460
   PubMedGoogle Scholar
• SafaeianMSolomonDCastlePECervical cancer prevention – cervical screening: science in evolutionObstet Gynecol Clin North Am200734473976018061867
   PubMed Web of Science ®Google Scholar
• United States Cancer StatisticsDepartment of Health and Human Services, Centers for Disease Control and Prevention Atlanta (GA), and National Cancer Institute: U S Cancer Statistics Working GroupUnited States Cancer Statistics: 1999–2007 Incidence and Mortality Web-based Report2010 Available from: http://apps.nccd.cdc.gov/uscs/Accessed June 21, 2011
   Google Scholar
• NandaKMcCroryDCMyersERAccuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic reviewAnn Intern Med20001321081081910819705
   PubMed Web of Science ®Google Scholar
• AdamsMJasaniBFianderAHuman papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screeningVaccine200725163007301317292517
   PubMed Web of Science ®Google Scholar
• GambleHLKloskyJLParraGRRandolphMEFactors influencing familial decision-making regarding human papillomavirus vaccinationJ Pediatr Psychol201035770471519966315
   PubMed Web of Science ®Google Scholar
• InsingaRPDasbachEJElbashaEHAssessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the USA: analytic framework and review of the literaturePharmacoeconomics200523111107112216277547
   PubMed Web of Science ®Google Scholar
• ArmstrongEPProphylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV typesJ Manag Care Pharm201016321723020331326
   PubMed Web of Science ®Google Scholar
• TechakehakijWFeldmanRDCost-effectiveness of HPV vaccination compared with Pap smear screening on a national scale: a literature reviewVaccine200826496258626518835313
   PubMed Web of Science ®Google Scholar
• PartridgeJMHughesJPFengQGenital human papillomavirus infection in men: incidence and risk factors in a cohort of university studentsJ Infect Dis200719681128113617955430
   PubMed Web of Science ®Google Scholar
• GiulianoARLuBNielsonCMAge-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US menJ Infect Dis2008198682783518657037
   PubMed Web of Science ®Google Scholar
• GiulianoARLeeJHFulpWIncidence and clearance of genital human papillomavirus infection in men (HIM): a cohort studyLancet2011377976993294021367446
   PubMed Web of Science ®Google Scholar
• DunneEFNielsonCMStoneKMMarkowitzLEGiulianoARPrevalence of HPV infection among men: a systematic review of the literatureJ Infect Dis200619481044105716991079
   PubMed Web of Science ®Google Scholar
• HullSCCaplanALThe case for vaccinating boys against human papillomavirusPublic Health Genomics2009125–636236719684448
   PubMed Web of Science ®Google Scholar
• TairaAVNeukermansCPSandersGDEvaluating human papillomavirus vaccination programsEmerg Infect Dis200410111915192315550200
   PubMed Web of Science ®Google Scholar
• ElbashaEHDasbachEJInsingaRPModel for assessing human papillomavirus vaccination strategiesEmerg Infect Dis2007131284117370513
   PubMed Web of Science ®Google Scholar
• KimJJGoldieSJCost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United StatesBMJ2009339b388419815582
   PubMed Web of Science ®Google Scholar
• BrissonMVan de VeldeNBoilyMCEconomic evaluation of human papillomavirus vaccination in developed countriesPublic Health Genomics2009125–634335119684446
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionReports of health concerns following HPV vaccination2011 Available from: http://www.cdc.gov/vaccinesafety/vaccines/hpv/gardasil.htmlAccessed May 19, 2011
   Google Scholar
• Centers for Disease Control and Prevention2009 Adult vaccination coverage, NHIS2009 Available from: http://www.cdc.gov/vaccines/stats-surv/nhis/2009-nhis.htmAccessed June 21, 2011
   Google Scholar
• Centers for Disease Control and PreventionNational, state, and local area vaccination coverage among adolescents aged 13–17 years – United States, 2009MMWR Morb Mortal Wkly Rep201059321018102320724968
   PubMedGoogle Scholar
• BachPBGardasil: From bench, to bedside, to blunderLancet2010375971996396420304226
   PubMed Web of Science ®Google Scholar
• American Cancer SocietyCancer Facts and Figures 2010Atlanta, GAAmerican Cancer Society2010
   Google Scholar
• D’SouzaGAgrawalYHalpernJBodisonSGillisonMLOral sexual behaviors associated with prevalent oral human papillomavirus infectionJ Infect Dis200919991263126919320589
   PubMed Web of Science ®Google Scholar
• LuBViscidiRPLeeJHHuman papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the Multinational HPV Infection in Men study (HIM study)Cancer Epidemiol Biomarkers Prev2011205990100221378268
   PubMed Web of Science ®Google Scholar
• PalefskyJMHuman papillomavirus-related disease in men: not just a women’s issueJ Adolesc Health2010464 SupplS12S1920307839
   PubMed Web of Science ®Google Scholar
• ChiaoEYGiordanoTPPalefskyJMTyringSEl SeragHScreening HIV-infected individuals for anal cancer precursor lesions: a systematic reviewClin Infect Dis200643222323316779751
   PubMed Web of Science ®Google Scholar
• KimJJTargeted human papillomavirus vaccination of men who have sex with men in the USA: A cost-effectiveness modelling analysisLancet Infect Dis2010101284585221051295
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionHIV/AIDS among youth2008 Available from: http://www.cdc.gov/hiv/resources/factsheets/youth.htmAccessed May 7, 2011
   Google Scholar
• FrischMBiggarRJGoedertJJHuman papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndromeJ Natl Cancer Inst200092181500151010995805
   PubMed Web of Science ®Google Scholar
• [No authors listed]1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adultsMMWR Recomm Rep199241RR-17119
   Google Scholar
• WilkinTLeeJYLensingSYSafety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected menJ Infect Dis201020281246125320812850
   PubMed Web of Science ®Google Scholar
• LevinMJMoscickiABSongLYSafety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years oldJ Acquir Immune Defic Syndr201055219720420574412
   PubMed Web of Science ®Google Scholar
• KleinJDAdolescent pregnancy: Current trends and issuesPediatrics2005116128128615995071
   PubMed Web of Science ®Google Scholar
• GarlandSMAultKAGallSAPregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trialsObstet Gynecol200911461179118819935017
   PubMed Web of Science ®Google Scholar
• SweetSCWongHHWebberSAPediatric transplantation in the United States,1995–2004Am J Transplant200665 Pt 21132115216613592
   PubMed Web of Science ®Google Scholar
• MaloufMAHopkinsPMSingletonLSexual health issues after lung transplantation: Importance of cervical screeningJ Heart Lung Transplant200423789489715261186
   PubMed Web of Science ®Google Scholar
• RoseBWilkinsDLiWHuman papillomavirus in the oral cavity of patients with and without renal transplantationTransplantation200682457057316926603
   PubMed Web of Science ®Google Scholar
• SeshadriLGeorgeSSVasudevanBKrishnaSCervical intraepithelial neoplasia and human papilloma virus infection in renal transplant recipientsIndian J Cancer2001382–4929512593446
   PubMedGoogle Scholar
• KloskyJLGambleHLSpuntSLHuman papillomavirus vaccination in survivors of childhood cancerCancer2009115245627563619813272
   PubMed Web of Science ®Google Scholar
• WiddiceLEBernsteinDILeonardACMarsoloKAKahnJAAdherence to the HPV vaccine dosing intervals and factors associated with completion of 3 dosesPediatrics20111271778421149425
   PubMed Web of Science ®Google Scholar
• StokleySUpdate: HPV Vaccination Coverage Among US Adolescent FemalesPresented at the Advisory Committee on Immunization Practices MeetingAtlanta, GAOctober 2010 Available from: http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-oct10/08-03-hpv-Female.pdfAccessed June 21, 2011
   Google Scholar
• NeubrandTPBreitkopfCRRuppRBreitkopfDRosenthalSLFactors associated with completion of the human papillomavirus vaccine seriesClin Pediatr2009489966969
   PubMed Web of Science ®Google Scholar
• American Cancer SocietyHow much does the HPV vaccine cost? Is it covered by health insurance plans?2011 Available from: http://www.cancer.org/Cancer/CancerCauses/OtherCarcinogens/InfectiousAgents/HPV/HumanPapillomaVirusandHPVVaccinesFAQ/hpv-faq-vaccine-costAccessed February 8, 2011
   Google Scholar
• Centers for Disease Control and PreventionVaccines for children program2011 Available from: http://www.cdc.gov/vaccines/programs/vfc/default.htmAccessed May 3, 2011
   Google Scholar
• Centers for Disease Control and PreventionFDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)2010 Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a5.htm?s_cid=mm5920a5_eAccessed May 2, 2011
   Google Scholar
• DaleyMFCraneLAMarkowitzLEHuman papillomavirus vaccination practices: A survey of US physicians 18 months after licensurePediatrics2010126342543320679306
   PubMed Web of Science ®Google Scholar
• DaleyMFLiddonNCraneLAA national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccinationPediatrics200611862280228917142510
   PubMed Web of Science ®Google Scholar
• KahnJAZimetGDBernsteinDIPediatricians’ intention to administer human papillomavirus vaccine: The role of practice characteristics, knowledge, and attitudesJ Adolesc Health200537650251016310128
   PubMed Web of Science ®Google Scholar
• KahnJARosenthalSLTissotAMFactors influencing pediatricians’ intention to recommend human papillomavirus vaccinesAmbul Pediatr20077536737317870645
   PubMedGoogle Scholar
• MarlowLAWardleJForsterASWallerJEthnic differences in human papillomavirus awareness and vaccine acceptabilityJ Epidemiol Community Health200963121010101519762455
   PubMed Web of Science ®Google Scholar
• ZimetGDRosenthalSLHPV vaccine and males: Issues and challengesGynecol Oncol20101172 SupplS26S3120129653
   PubMed Web of Science ®Google Scholar
• DempseyAFAbrahamLMDaltonVRuffinMUnderstanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirusAnn Epidemiol200919853153819394865
   PubMed Web of Science ®Google Scholar
• JonesMCookRIntent to receive an HPV vaccine among university men and women and implications for vaccine administrationJ Am Coll Health2008571233218682342
   PubMed Web of Science ®Google Scholar
• National Conference of State LegislaturesHPV Vaccine: State Legislation 2009–2010 Available from: http://www.ncsl.org/IssuesResearch/Health/HPVVaccineStateLegislation/tabid/14381/Default.aspxAccessed May 2, 2011
   Google Scholar
• OmerSBPanWKHalseyNANonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidenceJAMA2006296141757176317032989
   PubMed Web of Science ®Google Scholar
• PerkinsRBPierre-JosephNMarquezCIlokaSClarkJAParents’ opinions of mandatory human papillomavirus vaccination: does ethnicity matter?Womens Health Issues201020642042621051001
   PubMed Web of Science ®Google Scholar
• ParkinDMBrayFChapter 2: the burden of HPV-related cancersVaccine200624 Suppl 3S11S25
   Google Scholar
• Centers for Disease Control and Prevention2009 NIS-Teen Vaccination Coverage Table Data2011 Available from: http://www.cdc.gov/vaccines/stats-surv/nisteen/data/tables_2009.htmAccessed June 21, 2011
   Google Scholar
• Centers for Disease Control and PreventionNational, state, and local area vaccination coverage among adolescent aged 13–17 years – United States, 2008MMWR Morb Mortal Wkly Rep20095836997100119763075
   PubMedGoogle Scholar
• American Cancer SocietyGlobal Cancer Facts and Figures 2008Atlanta, GAAmerican Cancer Society2011
   Google Scholar
• World Health OrganizationHuman papillomavirus and related cancers in World WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre)2010 Available from: http://www.who.int/hpvcentre/en/Accessed June 21, 2011
   Google Scholar
• US Food and Drug AdministrationProduct approval prescribing information [Package insert]Gardasil [human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant]Whitehouse Station, NJMerck and Co, Inc2009 Available from: http://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm1123.pdfAccessed May 18, 2011
   Google Scholar
• US Food and Drug AdministrationProduct approval prescribing information [package insert]Cervarix [human papillomavirus bivalent (types 16 and 18) vaccine, recombinant]GlaxoSmithKline Biologicals2009 Available from: http://www.fda.gov/biologics-bloodvaccines/vaccines/approvedproducts/ucm186957.htmAccessed May 19, 2011
   Google Scholar
• Advisory Committee of Immunization PracticesNational Center for Immunization and Respiratory Diseases. General recommendations on immunizationMMWR Recomm Rep2011602164
   Google Scholar
• US Food and Drug AdministrationApproval letter: human papillomavirus bivalent (types 16,18) vaccine, recombinant10162009 Available from: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186959.htmAccessed May 8, 2011
   Google Scholar